PharVision Advisers’s Spire SR Stock Holding History

PharVision Advisers’s Portfolio SR Stock Details SR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,236	Closed	-$236K	–	787
2025 Q2	$236K	Buy	+3,236	New	+$242K	0.34%	155

Other funds holding SR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

DPIM

Duff & Phelps Investment Management Chicago, Illinois $9.63B AUM 11.3% 1-Year Est. Return

PharVision Advisers's SR Position: Q3 2025 in Review

PharVision Advisers sold out of Spire (SR) in Q3 2025, closing a stake of 3,236 shares — an estimated $236K sold.

PharVision Advisers first reported a position in SR in Q2 2025 and held it in 1 quarter. The position peaked at $236K in Q2 2025. 339 funds tracked by Wall St. Rank hold SR as of Q3 2025.

PharVision Advisers reported no remaining Spire position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 3,236 Spire shares in Q3 2025, an estimated $236K.
PharVision Advisers first reported a position in Spire in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Spire position peaked at $236K in Q2 2025.
339 funds tracked by Wall St. Rank held Spire as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.